KIOVEC Shuts Down mRNA Production
The company will complete current clinical studies but will not proceed to later development phases. KIOVEC reported a loss of more than 500 million euros for the completed quarter. The firm plans to shift its future focus toward cancer medication research.
Topics
Developing
- 893d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 893d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 893d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 893d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
BR24
“Für KIOVEC bedeutet das nun das endgültige Aus. Die Produktion werde geschlossen, laufende klinische Studien würden abgeschlossen und nicht in späteren Entwicklungsphasen weitergeführt”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade